Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-12-18

Clinical Trial Update: Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on Vitamin B12 status and response to supplementation in Parkinson's disease in a Phase 2/Phase 3 study; the trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin B12 (cobalamin)

Snippet

Sponsor: Emory University | Conditions: Parkinson's Disease | Phase 2, Phase 3 | Status: TERMINATED